Editas Medicine (EDIT)
(Real Time Quote from BATS)
$3.38 USD
-0.15 (-4.25%)
Updated Sep 25, 2024 03:00 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Brokerage Reports
Editas Medicine, Inc. [EDIT]
Reports for Purchase
Showing records 1 - 20 ( 105 total )
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Editas Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for EDIT 112123
Provider: Stock Traders Daily
Analyst: Research Department